Why adults living with HIV are at high risk for diabetes
A new UC San Francisco study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.
Aug 6, 2026
0
3
HIV & AIDS news
Once‑weekly HIV pill as effective as daily dose, research shows
Around 78% of people living with HIV take a daily pill to manage their infection. These drugs work by preventing HIV from multiplying.
Aug 5, 2026
0
4
New model maps where HIV is concentrated and the disease is more advanced
A new biostatistical modeling approach has the potential to support health decisions by pinpointing where HIV is concentrated and where people living with HIV are showing signs of severe immune suppression or delayed treatment. ...
Aug 5, 2026
0
10
Tumor-like tissue environments could hold clues to curing HIV
The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, reports a new Northwestern University study.
Aug 5, 2026
0
7
Doravirine works as well as dolutegravir to suppress HIV viral load, study finds
If you're a Black, 34-year-old South African woman living with HIV, antiretroviral (ARV) treatment options have likely been limited to tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and the "gold standard," dolutegravir ...
Aug 3, 2026
0
6
Risk of death 21% lower in patients with HIV-related fungal disease who were given combination drug treatment
In a clinical trial of adults with HIV-related cryptococcal disease, those treated with a two-drug combination had a 21% lower risk of dying than those treated with just one drug. This is according to City St George's research ...
Aug 3, 2026
0
4
Probiotic-derived bioactive metabolite reverses gut dysfunction and boosts HIV treatment response
Scientists at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in ...
Jul 30, 2026
0
90
International study shows once-weekly HIV pill performs as well as daily treatment
An international clinical trial led by researchers including Professor Chloe Orkin of Queen Mary University of London has shown that a once-weekly oral treatment for HIV is as effective as current leading daily therapies, ...
Jul 30, 2026
0
10
How US HIV funding cuts quickly affected care in East Africa
The U.S. government's withdrawal of funding for global HIV programs in January 2025 sharply reduced the number of people entering HIV care across East Africa within weeks, according to findings led by UC San Francisco researchers.
Jul 28, 2026
0
4
Four-paper series broadens sex workers' health focus beyond HIV prevention
A new four-paper series in The Lancet Public Health reflects a two-year collaboration among researchers at San Diego State University and the Johns Hopkins Bloomberg School of Public Health, the Global Network of Sex Work ...
Jul 28, 2026
0
12
